Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 10591-10600 Newer>

The Motley Fool November 7, 2005 Brian Gorman	Egg on Starbucks' Face? Starbucks' recent tests of a hot breakfast item, similar to the McDonald's Egg McMuffin, would seem like a reasonable idea. But this downscale shift is potentially dangerous. Investors, take note.
The Motley Fool November 7, 2005 Stephen D. Simpson	Perini Builds Its Book Construction is a lumpy business, but Perini is looking at several flush years of business. While there may yet be room for builders to run, the easy money has already been pocketed and investors should tread carefully with stock selection.
The Motley Fool November 7, 2005 Rich Smith	Foolish Forecast: Screening Pixar Analysts' fears of Pixar's demise seem overblown. Sure, revenues and profits are down -- but when a company's business model depends on producing films every 18 months, "lumpy" earnings are to be expected.
The Motley Fool November 7, 2005 Stephen D. Simpson	Powerwave Makes the Right Call Solid spending patterns for wireless equipment fuels a strong quarter for Powerwave. Investors, take note.
The Motley Fool November 7, 2005 Rick Aristotle Munarriz	4 Stocks That Took a Hike Companies with growing yields can make you rich in more ways than the obvious: Eaton Vance... Cryptologic... Wendy's International... Coca-Cola Enterprises...
The Motley Fool November 7, 2005 Mathew Emmert	Telecom's 8% Dividends This company may be Down Under, but its dividend is clearly over the top. Given the yield and the value in the shares, Telecom NZ is worth a look.
The Motley Fool November 7, 2005 Rick Aristotle Munarriz	Chicken Feed for Disney Disney's latest animated feature opens with mixed results. Investors, take note.
The Motley Fool November 4, 2005 Steven Mallas	How Sharp Is Saw II? Regardless of the success of the horror sequel, Lions Gate Entertainment is an interesting long-term play on the movie business for the more speculative side of one's portfolio.
The Motley Fool November 4, 2005 Chuck Saletta	Know Your Enemy If you want to minimize the number of mistakes you make in your investing choices, you have to keep a firm grasp on what a company you're considering is really worth.
The Motley Fool November 4, 2005 Stephen D. Simpson	A $99 Biotech Portfolio Can this biotech six-pack pay off for aggressive investors? Acadia Pharmaceuticals... Alexion Pharmaceuticals... Arena Pharmaceuticals... Crucell NV... DOV Pharmaceutical... Millennium Pharmaceuticals...
<Older 10591-10600 Newer> Return to current articles.